Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR studyManuel Anguita Sánchez, Marcelo Sanmartı́n, Vivencio Barrios et al.|Cardiology Journal|2022Cited by 3
Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxabanFrancisco Marı́n, Manuel Anguita Sánchez, Marcelo Sanmartı́n et al.|Journal of Comparative Effectiveness Research|2023Cited by 2
Poster session V * Saturday 11 December 2010, 08:30-12:30Quynh Hoa Pham, Thomas G. von Lueder, Silje K. Namtvedt et al.|European Journal of Echocardiography|2010Cited by 0